Literature DB >> 20631345

6-Mercaptopurine, monocytes, and atherosclerosis.

Macrae F Linton, Sergio Fazio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20631345      PMCID： PMC2922006          DOI： 10.1161/ATVBAHA.110.208264

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  21 in total

Review 1.  Atherosclerosis is an inflammatory disease.

Authors:  R Ross
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

2.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

3.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

Review 4.  Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency.

Authors:  Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-09-01       Impact factor: 8.311

Review 5.  Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice.

Authors:  Carlos J Cara; Amado Salvador Pena; Miquel Sans; Luis Rodrigo; Mercedes Guerrero-Esteo; Joaquín Hinojosa; Julio García-Paredes; Luis G Guijarro
Journal:  Med Sci Monit       Date:  2004-10-26

6.  Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.

Authors:  Daniel H Solomon; Jerry Avorn; Jeffrey N Katz; Michael E Weinblatt; Soko Setoguchi; Raisa Levin; Sebastian Schneeweiss
Journal:  Arthritis Rheum       Date:  2006-12

7.  Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study.

Authors:  Sahena Haque; Caroline Gordon; David Isenberg; Anisur Rahman; Peter Lanyon; Aubrey Bell; Paul Emery; Neil McHugh; Lee Suan Teh; David G I Scott; Mohamed Akil; Sophia Naz; Jacqueline Andrews; Bridget Griffiths; Helen Harris; Hazem Youssef; John McLaren; Veronica Toescu; Vinodh Devakumar; Jamal Teir; Ian N Bruce
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

8.  Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.

Authors:  Eugene Trogan; Jonathan E Feig; Snjezana Dogan; George H Rothblat; Véronique Angeli; Frank Tacke; Gwendalyn J Randolph; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-01       Impact factor: 11.205

Review 9.  Cardiovascular toxicities of immunosuppressive agents.

Authors:  Leslie W Miller
Journal:  Am J Transplant       Date:  2002-10       Impact factor: 8.086

10.  Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.

Authors:  L Havekes; E de Wit; J G Leuven; E Klasen; G Utermann; W Weber; U Beisiegel
Journal:  Hum Genet       Date:  1986-06       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.